Organogenesis Holdings Inc.

Organogenesis Holdings Inc. (Nasdaq: ORGO) is a regenerative medicine company focused on the development and commercialization of advanced wound care and surgical biologics products. The company entered public markets through a business combination with Avista Healthcare Public Acquisition Corp, a SPAC sponsored by Avista Capital Partners, which closed in December 2018. Operating in the healthcare and medical technology sector, Organogenesis serves both the chronic wound and surgical wound markets with bioactive and acellular product lines. The S-1/A amendment filed on November 10, 2020 reflects ongoing SEC registration activity following the merger. Visit SpacDesk and sign up for a free account to access the full filing history, deal structure, and institutional data for Organogenesis Holdings and hundreds of other SPAC transactions.